196 related articles for article (PubMed ID: 33721619)
21. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
[TBL] [Abstract][Full Text] [Related]
22. Wnt Signalling-Targeted Therapy in the CMS2 Tumour Subtype: A New Paradigm in CRC Treatment?
Albuquerque C; Pebre Pereira L
Adv Exp Med Biol; 2018; 1110():75-100. PubMed ID: 30623367
[TBL] [Abstract][Full Text] [Related]
23. An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas.
Yu S; Hornick JL; Gonzalez RS
Virchows Arch; 2021 Sep; 479(3):481-491. PubMed ID: 33733343
[TBL] [Abstract][Full Text] [Related]
24. Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study.
González-Montero J; Burotto M; Valenzuela G; Mateluna D; Buen-Abad F; Toro J; Barajas O; Marcelain K
World J Clin Oncol; 2023 Oct; 14(10):409-419. PubMed ID: 37970108
[TBL] [Abstract][Full Text] [Related]
25. Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer.
Purcell RV; Visnovska M; Biggs PJ; Schmeier S; Frizelle FA
Sci Rep; 2017 Sep; 7(1):11590. PubMed ID: 28912574
[TBL] [Abstract][Full Text] [Related]
26. Multilevel prioritization of gene regulators associated with consensus molecular subtypes of colorectal cancer.
Song K; Cai H; Zheng H; Yang J; Jin L; Xiao H; Zhang J; Zhao Z; Li X; Zhao W; Li X
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33855351
[TBL] [Abstract][Full Text] [Related]
27. Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancer.
Nguyen HG; Lundström O; Blank A; Dawson H; Lugli A; Anisimova M; Zlobec I
Mod Pathol; 2022 Feb; 35(2):240-248. PubMed ID: 34475526
[TBL] [Abstract][Full Text] [Related]
28. Integration of NRP1, RGS5, and FOXM1 expression, and tumour necrosis, as a postoperative prognostic classifier based on molecular subtypes of clear cell renal cell carcinoma.
Yoshida T; Ohe C; Ikeda J; Atsumi N; Saito R; Taniguchi H; Ohsugi H; Sugi M; Tsuta K; Matsuda T; Kinoshita H
J Pathol Clin Res; 2021 Nov; 7(6):590-603. PubMed ID: 34212534
[TBL] [Abstract][Full Text] [Related]
29. Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge.
Roy S; Smith MA; Cieply KM; Acquafondata MB; Parwani AV
Diagn Pathol; 2012 Nov; 7():151. PubMed ID: 23121893
[TBL] [Abstract][Full Text] [Related]
30. Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies.
Sveen A; Bruun J; Eide PW; Eilertsen IA; Ramirez L; Murumägi A; Arjama M; Danielsen SA; Kryeziu K; Elez E; Tabernero J; Guinney J; Palmer HG; Nesbakken A; Kallioniemi O; Dienstmann R; Lothe RA
Clin Cancer Res; 2018 Feb; 24(4):794-806. PubMed ID: 29242316
[No Abstract] [Full Text] [Related]
31. Validation of genetic classifiers derived from mouse and human tumors to identify molecular subtypes of colorectal cancer.
Snow SM; Matkowskyj KA; Maresh M; Clipson L; Vo TN; Johnson KA; Deming DA; Newton MA; Grady WM; Pickhardt PJ; Halberg RB
Hum Pathol; 2022 Jan; 119():1-14. PubMed ID: 34655611
[TBL] [Abstract][Full Text] [Related]
32. ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer.
Fernandez-De-Los-Reyes I; Gomez-Dorronsoro M; Monreal-Santesteban I; Fernandez-Fernandez A; Fraga M; Azcue P; Alonso L; Fernandez-Marlasca B; Suarez J; Cordoba-Iturriagagoitia A; Guerrero-Setas D
Clin Epigenetics; 2023 Dec; 15(1):193. PubMed ID: 38093305
[TBL] [Abstract][Full Text] [Related]
33. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
Nodin B; Johannesson H; Wangefjord S; O'Connor DP; Lindquist KE; Uhlén M; Jirström K; Eberhard J
Diagn Pathol; 2012 Aug; 7():115. PubMed ID: 22935204
[TBL] [Abstract][Full Text] [Related]
34. Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer.
Tarazona N; Gimeno-Valiente F; Gambardella V; Huerta M; Roselló S; Zuniga S; Calon A; Carbonell-Asins JA; Fontana E; Martinez-Ciarpaglini C; Eason K; Rentero-Garrido P; Fleitas T; Papaccio F; Moro-Valdezate D; Nyamundanda G; Castillo J; Espí A; Sadanandam A; Roda D; Cervantes A
ESMO Open; 2020 Sep; 5(5):e000847. PubMed ID: 32967918
[TBL] [Abstract][Full Text] [Related]
35. [Characterization of patients with sporadic colorectal cancer following the new Consensus Molecular Subtypes (CMS)].
Wielandt AM; Villarroel C; Hurtado C; Simian D; Zamorano D; Martínez M; Castro M; Vial MT; Kronberg U; López-Kostner F
Rev Med Chil; 2017 Apr; 145(4):419-430. PubMed ID: 28748988
[TBL] [Abstract][Full Text] [Related]
36. Improved Delineation of Colorectal Cancer Molecular Subtypes and Functional Profiles with a 62-Gene Panel.
Bhukdee D; Nuwongsri P; Israsena N; Sriswasdi S
Mol Cancer Res; 2023 Mar; 21(3):240-252. PubMed ID: 36490322
[TBL] [Abstract][Full Text] [Related]
37. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
[TBL] [Abstract][Full Text] [Related]
38. Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
Sirinukunwattana K; Domingo E; Richman SD; Redmond KL; Blake A; Verrill C; Leedham SJ; Chatzipli A; Hardy C; Whalley CM; Wu CH; Beggs AD; McDermott U; Dunne PD; Meade A; Walker SM; Murray GI; Samuel L; Seymour M; Tomlinson I; Quirke P; Maughan T; Rittscher J; Koelzer VH;
Gut; 2021 Mar; 70(3):544-554. PubMed ID: 32690604
[TBL] [Abstract][Full Text] [Related]
39. TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation.
Wu H; Lu XX; Wang JR; Yang TY; Li XM; He XS; Li Y; Ye WL; Wu Y; Gan WJ; Guo PD; Li JM
Autophagy; 2019 Sep; 15(9):1506-1522. PubMed ID: 30806153
[TBL] [Abstract][Full Text] [Related]
40. Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes.
Hirano D; Urabe Y; Tanaka S; Nakamura K; Ninomiya Y; Yuge R; Hayashi R; Oka S; Kitadai Y; Shimamoto F; Arihiro K; Chayama K
PLoS One; 2019; 14(2):e0211477. PubMed ID: 30785889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
